ArticleFrontiers in neurology2020

Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis.

Fei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.